132 related articles for article (PubMed ID: 27787376)
1. Clinical outcome in lung cancer with a second malignancy: The time sequence matters.
Lu MS; Chen MF; Huang YK; Liu HP; Tsai YH
Medicine (Baltimore); 2016 Oct; 95(43):e5203. PubMed ID: 27787376
[TBL] [Abstract][Full Text] [Related]
2. Second primary tumors involving non-small cell lung cancer: prevalence and its influence on survival.
Duchateau CS; Stokkel MP
Chest; 2005 Apr; 127(4):1152-8. PubMed ID: 15821189
[TBL] [Abstract][Full Text] [Related]
3. Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.
Faehling M; Schwenk B; Kramberg S; Fallscheer S; Leschke M; Sträter J; Eckert R
J Cancer Res Clin Oncol; 2018 Oct; 144(10):2059-2066. PubMed ID: 30062488
[TBL] [Abstract][Full Text] [Related]
4. Multiple Pulmonary Resections for Synchronous and Metachronous Lung Cancer at Two Chinese Centers.
Kang X; Zhang C; Zhou H; Zhang J; Yan W; Zhong WZ; Chen KN
Ann Thorac Surg; 2020 Mar; 109(3):856-863. PubMed ID: 31765616
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of a previous malignancy in operable non-small cell lung cancer.
Koppe MJ; Zoetmulder FA; van Zandwijk N; Hart AA; Baas P; Rutgers EJ
Lung Cancer; 2001 Apr; 32(1):47-53. PubMed ID: 11282428
[TBL] [Abstract][Full Text] [Related]
6. Surgical outcomes of second primary lung cancer after the extrapulmonary malignancy.
Ko KH; Huang HK; Chen YI; Chang H; Tsai WC; Huang TW
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3323-3332. PubMed ID: 32632580
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer as a second primary malignancy: increasing prevalence and its influence on survival.
Quadrelli S; Lyons G; Colt H; Chimondeguy D; Silva C
Ann Surg Oncol; 2009 Apr; 16(4):1033-8. PubMed ID: 19190966
[TBL] [Abstract][Full Text] [Related]
8. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
9. Natural history, clinical course and predictors of interval time from initial diagnosis to development of subsequent NSCLC brain metastases.
Smith DR; Bian Y; Wu CC; Saraf A; Tai CH; Nanda T; Yaeh A; Lapa ME; Andrews JIS; Cheng SK; McKhann GM; Sisti MB; Bruce JN; Wang TJC
J Neurooncol; 2019 May; 143(1):145-155. PubMed ID: 30874953
[TBL] [Abstract][Full Text] [Related]
10. Second primary lung cancer in Flanders: frequency, clinical presentation, treatment and prognosis.
Van Meerbeeck J; Weyler J; Thibaut A; Vansteenkiste J; Aumann J; Deneffe G; Galdermans D; Haelterman M; Joos G; Noppen M; Pinson P; Tasson J; van den Eeckhout A; Uydebrouck M
Lung Cancer; 1996 Nov; 15(3):281-95. PubMed ID: 8959675
[TBL] [Abstract][Full Text] [Related]
11. History of multiple previous malignancies should not be a contraindication to the surgical resection of lung cancer.
Pagès PB; Mordant P; Grand B; Badia A; Foucault C; Dujon A; Le Pimpec-Barthes F; Riquet M
Ann Thorac Surg; 2013 Mar; 95(3):1000-5. PubMed ID: 23375734
[TBL] [Abstract][Full Text] [Related]
12. Poor prognostic factors in patients with stage IB non-small cell lung cancer according to the seventh edition TNM classification.
Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
Chest; 2011 Apr; 139(4):855-861. PubMed ID: 20724736
[TBL] [Abstract][Full Text] [Related]
13. Second primary lung malignancy in head and neck cancer patients.
Dequanter D; Shahla M; Lardinois I; Gilbert O; Hanquet O; Tragas G; Van Meerhæghe A; Lothaire P
Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Jan; 128(1):11-3. PubMed ID: 20850406
[TBL] [Abstract][Full Text] [Related]
14. Risk of subsequent primary neoplasms developing in lung cancer patients with prior malignancies.
Brock MV; Alberg AJ; Hooker CM; Kammer AL; Xu L; Roig CM; Yang SC
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1119-25. PubMed ID: 15052211
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.
Reck M; Kaiser R; Mellemgaard A; Douillard JY; Orlov S; Krzakowski M; von Pawel J; Gottfried M; Bondarenko I; Liao M; Gann CN; Barrueco J; Gaschler-Markefski B; Novello S;
Lancet Oncol; 2014 Feb; 15(2):143-55. PubMed ID: 24411639
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and outcome of patients with second primary lung cancer.
Reinmuth N; Stumpf A; Stumpf P; Muley T; Kobinger S; Hoffmann H; Herth FJ; Schnabel PA; Warth A; Bischoff H; Thomas M
Eur Respir J; 2013 Dec; 42(6):1668-76. PubMed ID: 23060634
[TBL] [Abstract][Full Text] [Related]
17. Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer.
Heilbroner SP; Xanthopoulos EP; Buono D; Huang Y; Carrier D; Shah A; Kim J; Corradetti M; Wright JD; Neugut AI; Hershman DL; Cheng SK
Lung Cancer; 2019 Mar; 129():8-15. PubMed ID: 30797496
[TBL] [Abstract][Full Text] [Related]
18. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
Géczi L; Gomez F; Bak M; Bodrogi I
J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
[TBL] [Abstract][Full Text] [Related]
19. Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC).
Figueiredo A; Almeida MA; Almodovar MT; Alves P; Araújo A; Araújo D; Barata F; Barradas L; Barroso A; Brito U; Camacho E; Canário D; Cardoso T; Chaves A; Costa L; Cunha J; Duarte J; Estevinho F; Felizardo M; Fernandes JP; Ferreira L; Ferreira L; Fidalgo P; Freitas C; Garrido P; Gil N; Hasmucrai D; Jesus E; Lopes JA; de Macedo JE; Meleiro A; Neveda R; Nogueira F; Pantorotto M; Parente B; Pego A; Rocha M; Roque J; Santos C; Saraiva J; Silva E; Silva S; Simões S; Soares M; Teixeira E; Timóteo T; Hespanhol V
Pulmonology; 2020; 26(1):10-17. PubMed ID: 31630986
[TBL] [Abstract][Full Text] [Related]
20. Synchronous non-small cell lung cancers: diagnostic yield can be improved by histologic and genetic methods.
Zhang Y; Hu H; Wang R; Ye T; Pan Y; Wang L; Zhang Y; Li H; Li Y; Shen L; Yu Y; Sun Y; Chen H; Garfield D
Ann Surg Oncol; 2014 Dec; 21(13):4369-74. PubMed ID: 25081337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
